2024 has been a year of significant progress for CheckEye, as we continue our journey toward revolutionizing healthcare through the use of AI in chronic disease prevention. One of the most impactful moments of this year has been securing financial support from the Business Bridge project under Ukraine-Ready4EU, supported by the European Union. This support not only enhances our capacity for growth but also strengthens our mission to bring life-changing healthcare solutions to more people across Europe.
The Business Bridge project under Ukraine-Ready4EU was created to help Ukrainian companies expand their reach and participate in European innovation ecosystems. By supporting promising startups like CheckEye, the initiative fosters cross-border cooperation and knowledge sharing, providing a platform for developing cutting-edge solutions in various fields, including healthcare.
This financial backing comes at a crucial time as we continue our efforts to scale our AI-driven healthcare solutions. CheckEye is focused on using artificial intelligence to detect early signs of chronic diseases, helping prevent complications before they can drastically affect people’s lives. This financial support empowers us to enhance our technological infrastructure and expand our footprint in the European market.
Thanks to the Ready4EU financial support, we had the opportunity to showcase CheckEye at EURETINA 2024, one of the most influential events in the field of retinal health. Held in Barcelona, this prestigious conference brings together global experts, thought leaders, and innovators in ophthalmology. Our participation at EURETINA allowed us to present our vision and AI-powered solutions to a wider audience, creating valuable connections and strengthening our presence in the international healthcare community.
EURETINA also provided a unique opportunity to network with potential partners and explore future collaborations, which could accelerate our mission to improve global healthcare outcomes through early detection of chronic diseases, particularly those related to retinal health.
The support from Business Bridge under Ukraine-Ready4EU has opened doors to new partnerships and collaborations across Europe. The financial backing has facilitated our participation in international events, enhanced our visibility, and positioned us to have a greater impact in the healthcare sector.
With this newfound visibility, CheckEye is now in a stronger position to collaborate with other innovators and institutions, ultimately benefiting patients across Europe. The European Union’s support is a significant step toward achieving our vision of providing accessible, high-quality, AI-powered diagnostic solutions to tackle chronic diseases at their roots.
The road ahead is full of exciting opportunities. The financial support from Ukraine-Ready4EU is just the beginning of an even greater journey. As we continue to scale and refine our platform, CheckEye remains committed to leveraging AI to create innovative healthcare solutions that can save lives, improve quality of life, and reduce the burden of chronic diseases on healthcare systems.
Our participation in global events like EURETINA 2024 and our ongoing collaborations across Europe underscore the potential of AI to revolutionize healthcare for the better. We are incredibly grateful to the European Union for their backing and are excited to continue building on this momentum, bringing CheckEye’s transformative solutions to even more people in the near future.
The financial support from the Business Bridge project under Ukraine-Ready4EU marks a critical milestone in CheckEye’s growth, enabling us to scale our AI-driven healthcare solutions, expand our network, and increase our impact across Europe. We are excited for the next steps in our journey and remain committed to transforming the healthcare landscape through innovative technology.
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.